was not only shown to function as a coactivator for p53-mediated transcription, but also its overexpression resulted in enhancement of p53-independent gene expression ( To elucidate the molecular mechanism by which BRCA1 induces such a broad range of effects, we isolated the predominant BRCA1-containing complex from Summary HeLa cells and identified its components by mass spectrometric peptide sequencing. Here we show that Germline mutations in the tumor suppressor gene, BRCA1 is a component of a human SWI/SNF-related BRCA1, predispose individuals to breast and ovarian complex. We have isolated the BRCA1 complex using cancers. Using a combination of affinity-and conventhree independent approaches, resulting in a similar tional chromatographic techniques, we have isolated polypeptide composition. These data not only provide a predominant form of a multiprotein BRCA1-containa clear connection between BRCA1 and transcriptional ing complex from human cells displaying chromatinregulatory machinery, but also point to the other comporemodeling activity. Mass spectrometric sequencing of nents of the SWI/SNF complex as potential genes whose components of this complex indicated that BRCA1 is mutations may result in breast and ovarian cancers. associated with a SWI/SNF-related complex. We show that BRCA1 can directly interact with the BRG1 subunit Results of the SWI/SNF complex. Moreover, p53-mediated stimulation of transcription by BRCA1 was completely Affinity-Purification of a BRCA1 Complex abrogated by either a dominant-negative mutant of To determine the polypeptide composition of endoge-BRG1 or the cancer-causing deletion in exon 11 of nous BRCA1-containing complex(es), HeLa nuclear ex-BRCA1. These findings reveal a direct function for tract was chromatographed sequentially to enrich for BRCA1 in transcriptional control through modulation BRCA1-containing complex(es) ( Figure 1A ). Analysis of of chromatin structure.
Introduction cel fractions were subjected to affinity-purification using polyclonal anti-BRCA1 antibodies. Polypeptides specifi-BRCA1 is a tumor suppressor gene that is linked to cally eluted from the BRCA1 affinity matrix ( Figure 1B ) familial breast and ovarian cancers (Hall et al., 1990;  were sequenced by ion trap tandem mass spectrometry. Miki et al., 1994) . The BRCA1 gene encodes a protein Twenty-six tryptic peptide sequences confirmed the of 1863 amino acids without extensive homology to identity of the 210 kDa polypeptide as BRCA1, indicating other proteins in the database (Miki et al., 1994) . The that the purification was specific. However, the yields primary sequence contains two motifs characteristic of for the BRCA1 protein were variable in different preparatranscription factors (Miki et al., 1994) . These include tions, as it could not be efficiently eluted from the affinity a RING-finger motif and an acidic carboxyl terminus. matrix. tide as human BRG1 protein. The 60 kDa polypeptide of BRCA1 with SWI/SNF complex, we analyzed the BRCA1-affinity eluate in a mononucleosome digestion assay. As Figure 1C indicates the affinity-purified BRCA1 complex displayed chromatin remodeling activity by altering the ATP-dependent DNase I cleavage of mononucleosomes to a pattern which more closely resembled that of naked DNA. These results revealed a physical association of the BRCA1 protein with the SWI/ SNF chromatin remodeling complex.
BRCA1-SWI/SNF Is a Predominant Human BRCA1-Containing Complex
BRCA1 is reported to be a component of number of different complexes (Scully et al., 1997a (Scully et al., , 1999 Zhong et al., 1999) . To confirm the association of BRCA1 and the SWI/SNF-related complexes and to gain some insight into the number of BRCA1-containing complexes, we purified the BRCA1 complex(es) to near homogeneity by fractionating HeLa nuclear extract following the scheme shown in Figure 2A . Western blot analysis of column fractions throughout the entire purification steps revealed the precise coelution of BRCA1 and the components of the SWI/SNF complex ( Figures 2B and 2C ). It is noteworthy that only a single peak of BRCA1 immunoreactivity was detected on every column, and this peak coeluted with components of the SWI/SNF complex ( Figures 2B, 2C , and 3B). These results indicate that BRCA1-SWI/SNF represent the predominant BRCA1-containing complex in HeLa nuclear extract.
Similar to the affinity-purified BRCA1-SWI/SNF complex, the conventionally purified complex displayed mononucleosome disruption activity ( Figure 2C ). Figure 2D displays the polypeptide composition of the BRCA1- indicated that BRCA1 and RNAPII have different elution profiles ( Figure 3B) . Thus, the BRCA1-SWI/SNF complex is not a component of a human RNA polymerase II contained three peptide sequences corresponding to BAF60b. BRG1 and BAF60 were reported to be compocomplex. BRCA1 was also shown to be in a stable complex nents of the multiprotein human chromatin remodeling complex, SWI/SNF (Wang et al., 1996a (Wang et al., , 1996b BRG1, we performed protein-protein interaction studies 
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